A systematic review from the University of St Andrews has surfaced what many clinicians long suspected but rarely quantified: women presenting with the same diagnoses as men are consistently offered less aggressive, less interventionist care — not because medicine recommends it, but because something quieter and more troubling appears to be shaping the decision. Across cardiology, surgery, transplant medicine, and emergency care, the pattern held firm even after controlling for confounding variables, leaving researchers to confront a gap that clinical guidelines do not justify and medical ethi
Study reveals women receive less active medical treatment than men for same conditions
Women with serious medical conditions receive less aggressive treatment than men, potentially affecting health outcomes and survival rates across multiple disease categories.
Women are less likely to be offered the same active treatments as men
Mark
So they looked at over a thousand studies and found that women get less aggressive treatment. How confident are we that this is actually bias and not something else?
Mimi
The researchers narrowed it down to 38 studies that directly compared men and women with the same conditions. Thirty-three of those showed significant differences. That's a pretty consistent signal.
Luke
But here's what I want to know: did they control for everything? Like, could women be presenting later in disease progression, or refusing treatment more often, or something we're not seeing in the data?
Mimi
That's fair. The studies they reviewed did adjust for other variables in most cases, but you're right that not every confounding factor can be captured. The real puzzle is that there's no guideline saying to treat women differently.
Mark
So doctors are making these choices without any official backing. That's the concerning part.
Luke
Or it could mean the guidelines are just poorly applied. We don't actually know if a doctor is consciously choosing to offer less treatment or if something subtler is happening—like women being less assertive about asking for options, or doctors making different assumptions about what women want.
Mimi
One of the studies they cited found that when the decision-making process itself was weak—poor communication in the committee—women were less likely to get selected for advanced therapy. That suggests the bias isn't necessarily intentional.
Mark
And the AI question at the end—that seems like the real warning. If we train machines on biased data, we just automate the problem.
Luke
True, but we don't know yet whether AI will actually replicate these patterns or whether it might even correct for them. That's still an open question.
Mimi
Which is exactly why they're studying it now, before these systems become standard in hospitals.
Der Puls
- Thirty-three of 38 comparative studies confirmed it: women with identical conditions to male patients are routinely offered less surgery, fewer stents, weaker painkillers, and fewer aggressive interventions — with no clinical guidelines to explain why.
- The disparity cuts across specialties and persists even after researchers strip away other variables, suggesting the gap is not incidental but structural — woven into how medicine evaluates and responds to women's bodies.
- Doctors appear more likely to attribute women's symptoms to anxiety or psychological causes even when objective tests point elsewhere, compounding diagnostic errors that steer patients away from treatments they may urgently need.
- The problem has deep roots: decades of clinical trials built on predominantly male subjects have produced guidelines that may simply fail to account for how conditions present or progress differently in women.
- The St Andrews team is now racing to determine whether AI systems trained on this same biased literature could amplify these disparities at scale — potentially entrenching unequal care across global healthcare systems before the problem is corrected.
A systematic review from the University of St Andrews has surfaced what many clinicians long suspected but rarely quantified: women presenting with the same diagnoses as men are consistently offered less aggressive, less interventionist care — not because medicine recommends it, but because something quieter and more troubling appears to be shaping the decision. Across cardiology, surgery, transplant medicine, and emergency care, the pattern held firm even after controlling for confounding variables, leaving researchers to confront a gap that clinical guidelines do not justify and medical ethics cannot easily absorb. The study is less a revelation than a reckoning — a formal accounting of how the assumptions embedded in research history and clinical habit may be quietly altering the life chances of half the population.
Researchers at the University of St Andrews have formally documented what many in medicine have long sensed: women arriving with the same diagnoses as men are significantly less likely to be offered the most active, potentially life-altering treatments available. The finding emerges from a systematic review published in PLOS One, which examined 1,112 studies on gender and medical care before narrowing to 38 that directly compared treatment decisions across sexes. Of those, 33 reported statistically significant differences — women consistently receiving less aggressive interventions across cardiology, surgery, transplant medicine, and emergency departments, even after other variables were accounted for.
What unsettled the researchers most was not the existence of the gap but its consistency — and the near-total absence of clinical guidelines that would justify it. Co-lead researcher Dr. Andrew O'Malley identified specific mechanisms at work: poorly functioning hospital committees were less likely to select women for advanced heart failure therapies, and doctors more frequently attributed women's symptoms to anxiety even when physical test results suggested otherwise. These errors, compounding quietly across consultations, may be redirecting women away from care they need.
The historical record offers partial explanation. Women were systematically underrepresented in the clinical trials that underpin modern medical guidelines, meaning many protocols were built on data drawn primarily from male bodies. Dr. Miriam Veenhuizen highlighted a telling imbalance: 551 studies examined gender inequalities affecting healthcare workers themselves, while only 41 examined what happens to patients.
The team is now turning its attention to a forward-looking concern: whether AI systems trained on this same male-centered literature might entrench these disparities at scale, affecting millions of patients simultaneously as the technology becomes more embedded in clinical decision-making. For now, the study stands as a documented call to clinicians — that treatment decisions must rest on evidence, not assumption — though whether it will be enough to shift patterns long settled into habit remains an open question.
Researchers at the University of St Andrews have documented a persistent pattern across modern medicine: when men and women arrive with identical diagnoses, women are significantly less likely to be offered aggressive interventions—surgery, stents, strong painkillers, or other active treatments that might alter the course of their illness.
The finding comes from a systematic review published in PLOS One that examined 1,112 published studies on gender and medical care. The researchers narrowed their focus to 38 studies that directly compared treatment decisions for male and female patients with the same conditions. Of those 38, thirty-three reported statistically significant differences in what men and women were offered. The disparity appeared across multiple medical domains: cardiology, general surgery, transplant medicine, and emergency departments. It persisted even after researchers adjusted for other variables that might explain the gap.
What made the discovery particularly striking was not that such differences existed—clinicians and researchers have long suspected gender bias in medicine—but rather the consistency of the pattern and the absence of any clinical justification for it. The St Andrews team found almost no medical guidelines that actually recommend different treatment approaches based on sex. This leaves an uncomfortable question: are these differences the result of sound clinical reasoning, or do they reflect something closer to systematic inequality in how doctors evaluate and treat their female patients?
Dr. Andrew O'Malley, who co-led the research, pointed to specific mechanisms that might explain the gap. One study his team reviewed found that when the committees responsible for selecting patients for advanced heart failure treatment functioned poorly—with weak communication or unclear decision-making processes—women were less likely to be chosen for the therapy. Other research suggests doctors more frequently attribute women's symptoms to psychological causes like anxiety, even when objective test results point to a physical problem. These diagnostic errors compound over time, potentially steering women away from treatments they need.
The researchers traced part of the problem to the history of clinical research itself. Until recent decades, women were systematically underrepresented in the trials that form the foundation of modern medical guidelines. Many of the protocols doctors follow today rest on data gathered primarily from male bodies. This historical imbalance may have created guidelines that, while not explicitly gender-biased, fail to account for how conditions present or progress differently in women. Dr. Miriam Veenhuizen, an honorary lecturer involved in the study, noted the striking imbalance in research attention: over the same period that 551 studies examined sex-based inequalities affecting healthcare workers themselves, only 41 examined what actually happens to patients.
The implications extend beyond current clinical practice. The St Andrews team is now investigating whether artificial intelligence systems trained on this same medical literature and clinical records might amplify these disparities at scale. If AI tools inherit the biases embedded in decades of male-centered research and practice patterns, they could entrench unequal treatment across healthcare systems worldwide—potentially affecting millions of patients simultaneously. The researchers see this as an urgent question that needs answering before these systems become more deeply integrated into clinical decision-making.
For now, the study serves as a documented reminder to clinicians that treatment decisions should rest on clinical evidence, not assumption. Whether that reminder will be enough to shift entrenched patterns remains to be seen.
Bemerkenswerte Zitate
For clinicians, the findings are a prompt to check whether treatment is being offered on clinical grounds rather than assumption.— Dr. Andrew O'Malley, University of St Andrews
The same pattern appeared in cardiology, surgery, transplant medicine and emergency care, and it survived statistical adjustment in most studies.— Dr. Miriam Veenhuizen, University of St Andrews
Möchten Sie die ganze Geschichte?
Das Original lesen bei News-Medical ↗
Health & Medicine